Approvals/TGA/OPDIVO nivolumab 40 mg in 4 mL (10 mg/mL) concentrated solution for IV infusion vial

Approved

STANDARD

OPDIVO nivolumab 40 mg in 4 mL (10 mg/mL) concentrated solution for IV infusion vial

Bristol-Myers Squibb Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 36cf503d70342315
Product Name: OPDIVO nivolumab 40 mg in 4 mL (10 mg/mL) concentrated solution for IV infusion vial
Artg Id: 231867
Artg Name: OPDIVO nivolumab 40 mg in 4 mL (10 mg/mL) concentrated solution for IV infusion vial
Sponsor: Bristol-Myers Squibb Australia Pty Ltd
Company Detail Path: /organization/bristol-myers-squibb-australia-pty-ltd
Artg Date: 2016-01-11
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/175f44938771b8606c7d26bc3424affa.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/c9ea720ec86d6f810533595273c82b5b.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

36cf503d70342315

Type

Standard